This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by MacDonald, C. J. Articles by Yeh, G. C. Search for Related Content PubMed PubMed Citation Articles by MacDonald, C. J. Articles by Yeh, G. C.

Dibenzoylmethane Modulates Aryl Hydrocarbon Receptor Function and Expression of Cytochromes P450 1A1, 1A2, and 1B1

Cellular Defense and Carcinogenesis Section, Basic Research Laboratory, Division of Basic Sciences, National Cancer Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702-1201

The phytochemical dibenzoylmethane (DBM) has been shown to prevent polycyclic aromatic hydrocarbon (PAH)-induced tumorigenesis in rodents. However, the biochemical basis of this activity is unclear. We have therefore investigated the effects of DBM on the activity and expression of carcinogen-activating enzymes, the cytochromes P450 (CYP) 1A1, 1A2, and 1B1. Oral administration of DBM to female Sprague Dawley rats inhibited the increase in hepatic enzyme activity and mRNA levels of CYP1A1, 1A2, and 1B1 caused by the PAH 7,12-dimethylbenz[a]anthracene (DMBA). However, DBM administration alone caused an increase in both activity and expression in the liver, albeit to levels much lower than that induced by DMBA. To characterize the molecular mechanisms involved in this dual action of DBM, we examined the effects of DBM in vitro. In HepG2 human hepatoma cells, DBM inhibited DMBA- and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced enzyme activity and CYP1A1, 1A2, and 1B1 mRNA levels, whereas DBM itself induced activity and mRNA expression. Modulation of CYP1A1 expression by DBM occurred at the transcriptional level, as transient transfection assays demonstrated. Because the transcription of CYP1A1 is regulated by the aryl hydrocarbon receptor (AhR), we investigated the effect of DBM on AhR activation. DBM inhibited TCCD-induced DNA-binding of the AhR to the xenobiotic-responsive element (XRE) of CYP1A1 as measured by electrophoretic mobility shift assay. These data suggest that the chemopreventive activity of DBM results from its ability to affect Phase 1 enzyme expression by modulation of AhR function.

This article has been cited by other articles:

				P. Sienkiewicz, H. P. Ciolino, B. J. Leslie, P. J. Hergenrother, K. Singletary, and G. C. Yeh A novel synthetic analogue of a constituent of Isodon excisus inhibits transcription of CYP1A1, -1A2 and -1B1 by preventing activation of the aryl hydrocarbon receptor Carcinogenesis, May 1, 2007; 28(5): 1052 - 1057. [Abstract] [Full Text] [PDF]

				Y. R. Pokharel, E. H. Han, J. Y. Kim, S. J. Oh, S. K. Kim, E.-R. Woo, H. G. Jeong, and K. W. Kang Potent protective effect of isoimperatorin against aflatoxin B1-inducible cytotoxicity in H4IIE cells: bifunctional effects on glutathione S-transferase and CYP1A Carcinogenesis, December 1, 2006; 27(12): 2483 - 2490. [Abstract] [Full Text] [PDF]

				H. P. Ciolino, C. J. MacDonald, O. S. Memon, S. E. Bass, and G. C. Yeh Sulindac regulates the aryl hydrocarbon receptor-mediated expression of Phase 1 metabolic enzymes in vivo and in vitro Carcinogenesis, August 1, 2006; 27(8): 1586 - 1592. [Abstract] [Full Text] [PDF]

				C.-C. Lin, Y.-L. Tsai, M.-T. Huang, Y.-P. Lu, C.-T. Ho, S.-F. Tseng, and S.-C. Teng Inhibition of estradiol-induced mammary proliferation by dibenzoylmethane through the E2-ER-ERE-dependent pathway Carcinogenesis, January 1, 2006; 27(1): 131 - 136. [Abstract] [Full Text] [PDF]

				C. J. MacDonald, H. P. Ciolino, and G. C. Yeh The Drug Salicylamide Is an Antagonist of the Aryl Hydrocarbon Receptor That Inhibits Signal Transduction Induced by 2,3,7,8-Tetrachlorodibenzo-p-dioxin Cancer Res., January 1, 2004; 64(1): 429 - 434. [Abstract] [Full Text] [PDF]

				H. P. Ciolino, C. J. MacDonald, and G. C. Yeh Inhibition of Carcinogen-activating Enzymes by 16{alpha}-Fluoro-5-androsten-17-one Cancer Res., July 1, 2002; 62(13): 3685 - 3690. [Abstract] [Full Text] [PDF]